Isabelle Mercier, Ph.D. - Publications

Affiliations: 
2004 Université de Montréal, Montréal, Canada 
Area:
Molecular Biology, Biochemistry

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Danilo C, Gutierrez-Pajares JL, Mainieri MA, Mercier I, Lisanti MP, Frank PG. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development Breast Cancer Research. 15. PMID 24060386 DOI: 10.1186/bcr3483  0.56
2013 Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, Lisanti MP, Jasmin JF. Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide Cell Cycle. 12: 1510-1520. PMID 23598719 DOI: 10.4161/cc.24497  0.56
2012 Mercier I, Camacho J, Titchen K, Gonzales DM, Quann K, Bryant KG, Molchansky A, Milliman JN, Whitaker-Menezes D, Sotgia F, Jasmin JF, Schwarting R, Pestell RG, Blagosklonny MV, Lisanti MP. Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. The American Journal of Pathology. 181: 278-93. PMID 22698676 DOI: 10.1016/j.ajpath.2012.03.017  0.56
2012 Mercier I, Lisanti MP. Caveolin-1 and breast cancer: a new clinical perspective. Advances in Experimental Medicine and Biology. 729: 83-94. PMID 22411315 DOI: 10.1007/978-1-4614-1222-9_6  0.56
2012 Pavlides S, Vera I, Gandara R, Sneddon S, Pestell RG, Mercier I, Martinez-Outschoorn UE, Whitaker-Menezes D, Howell A, Sotgia F, Lisanti MP. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxidants & Redox Signaling. 16: 1264-84. PMID 21883043 DOI: 10.1089/ars.2011.4243  0.56
2011 Bryant KG, Camacho J, Jasmin JF, Wang C, Addya S, Casimiro MC, Fortina P, Balasubramaniam S, Knudsen KE, Schwarting R, Lisanti MP, Mercier I. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. The International Journal of Biochemistry & Cell Biology. 43: 1318-29. PMID 21601007 DOI: 10.1016/j.biocel.2011.04.019  0.56
2011 Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology. 300: H1274-81. PMID 21297026 DOI: 10.1152/ajpheart.01173.2010  0.56
2011 Llaverias G, Danilo C, Mercier I, Daumer K, Capozza F, Williams TM, Sotgia F, Lisanti MP, Frank PG. Role of cholesterol in the development and progression of breast cancer. The American Journal of Pathology. 178: 402-12. PMID 21224077 DOI: 10.1016/j.ajpath.2010.11.005  0.56
2010 Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, Tsirigos A, Migneco G, Witkiewicz A, Balliet R, Mercier I, Wang C, Flomenberg N, Howell A, Lin Z, et al. The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox. Cell Cycle (Georgetown, Tex.). 9: 4297-306. PMID 21051947 DOI: 10.4161/cc.9.21.13817  0.56
2009 Witkiewicz AK, Casimiro MC, Dasgupta A, Mercier I, Wang C, Bonuccelli G, Jasmin JF, Frank PG, Pestell RG, Kleer CG, Sotgia F, Lisanti MP. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy. Cell Cycle (Georgetown, Tex.). 8: 1654-8. PMID 19448435  0.56
2009 Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, Zhou J, Dew E, Capozza F, Daumer KM, Minetti C, Milliman JN, Alpy F, Rio MC, Tomasetto C, ... Mercier I, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. The American Journal of Pathology. 174: 1650-62. PMID 19395651 DOI: 10.2353/ajpath.2009.080648  0.56
2009 Mercier I, Bryant KG, Sotgia F, Bonuccelli G, Witkiewicz AK, Dasgupta A, Jasmin JF, Pestell RG, Lisanti MP. Using Caveolin-1 epithelial immunostaining patterns to stratify human breast cancer patients and predict the Caveolin-1 (P132L) mutation Cell Cycle. 8: 1396-1401. PMID 19342880  0.56
2009 Mercier I, Casimiro MC, Zhou J, Wang C, Plymire C, Bryant KG, Daumer KM, Sotgia F, Bonuccelli G, Witkiewicz AK, Lin J, Tran TH, Milliman J, Frank PG, Jasmin JF, et al. Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions. The American Journal of Pathology. 174: 1172-90. PMID 19342371 DOI: 10.2353/ajpath.2009.080882  0.56
2009 Mercier I, Jasmin JF, Pavlides S, Minetti C, Flomenberg N, Pestell RG, Frank PG, Sotgia F, Lisanti MP. Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 614-23. PMID 19333235 DOI: 10.1038/labinvest.2009.23  0.56
2009 Sotgia F, Del Galdo F, Casimiro MC, Bonuccelli G, Mercier I, Whitaker-Menezes D, Daumer KM, Zhou J, Wang C, Katiyar S, Xu H, Bosco E, Quong AA, Aronow B, Witkiewicz AK, et al. Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. The American Journal of Pathology. 174: 746-61. PMID 19234134 DOI: 10.2353/ajpath.2009.080658  0.56
2009 Sotgia F, Casimiro MC, Bonuccelli G, Liu M, Whitaker-Menezes D, Er O, Daumer KM, Mercier I, Witkiewicz AK, Minetti C, Capozza F, Gormley M, Quong AA, Rui H, Frank PG, et al. Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation. The American Journal of Pathology. 174: 613-29. PMID 19164602 DOI: 10.2353/ajpath.2009.080653  0.56
2008 Mercier I, Vuolo M, Jasmin JF, Medina CM, Williams M, Mariadason JM, Qian H, Xue X, Pestell RG, Lisanti MP, Kitsis RN. ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer Cell Cycle. 7: 1640-1647. PMID 18469522  0.56
2008 Mercier I, Casimiro MC, Wang C, Rosenberg AL, Quong J, Minkeu A, Allen KG, Danilo C, Sotgia F, Bonuccelli G, Jasmin JF, Xu H, Bosco E, Aronow B, Witkiewicz A, et al. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy Cancer Biology and Therapy. 7: 1212-1225. PMID 18458534  0.56
2007 Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP. Caveolin-1 deficiency increases cerebral ischemic injury. Circulation Research. 100: 721-9. PMID 17293479 DOI: 10.1161/01.RES.0000260180.42709.29  0.56
2006 Sotgia F, Rui H, Bonuccelli G, Mercier I, Pestell RG, Lisanti MP. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers. Cancer Research. 66: 10647-51. PMID 17108100 DOI: 10.1158/0008-5472.CAN-06-2805  0.56
2006 Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP. Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy Circulation. 114: 912-920. PMID 16940204 DOI: 10.1161/CIRCULATIONAHA.106.634709  0.56
2006 Jasmin JF, Mercier I, Sotgia F, Lisanti MP. SOCS proteins and caveolin-1 as negative regulators of endocrine signaling Trends in Endocrinology and Metabolism. 17: 150-158. PMID 16616514 DOI: 10.1016/j.tem.2006.03.007  0.56
2004 Jasmin JF, Mercier I, Hnasko R, Cheung MW, Tanowitz HB, Dupuis J, Lisanti MP. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovascular Research. 63: 747-55. PMID 15306231 DOI: 10.1016/j.cardiores.2004.05.018  0.56
2003 Pham-Dang ML, Clement R, Mercier I, Calderone A. Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat. Canadian Journal of Physiology and Pharmacology. 81: 915-9. PMID 14614530 DOI: 10.1139/y03-086  0.8
2003 Thorin E, Pham-Dang M, Clement R, Mercier I, Calderone A. Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen. British Journal of Pharmacology. 140: 1187-92. PMID 14597597 DOI: 10.1038/sj.bjp.0705547  0.8
2003 Mercier I, Mader S, Calderone A. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism. Cardiovascular Research. 59: 883-92. PMID 14553828 DOI: 10.1016/S0008-6363(03)00517-0  0.56
2002 Mercier I, Pham-Dang M, Clement R, Gosselin H, Colombo F, Rouleau JL, Calderone A. Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis. British Journal of Pharmacology. 136: 685-92. PMID 12086977 DOI: 10.1038/sj.bjp.0704765  0.8
2002 Sanchez R, MacKenzie A, Farhat N, Nguyen TD, Stewart DJ, Mercier I, Calderone A, Thorin E. Endothelin B receptor-mediated regulation of endothelin-1 content and release in cultured porcine aorta endothelial cell. Journal of Cardiovascular Pharmacology. 39: 652-9. PMID 11973408  0.8
2002 Mercier I, Colombo F, Mader S, Calderone A. Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation. Cardiovascular Research. 53: 728-39. PMID 11861043 DOI: 10.1016/S0008-6363(01)00525-9  0.56
2001 Abdelaziz N, Colombo F, Mercier I, Calderone A. Nitric oxide attenuates the expression of transforming growth factor-beta(3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension. 38: 261-6. PMID 11509487  0.8
2001 Colombo F, Noël J, Mayers P, Mercier I, Calderone A. beta-Adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. Journal of Molecular and Cellular Cardiology. 33: 1091-106. PMID 11444915 DOI: 10.1006/jmcc.2001.1381  0.8
Show low-probability matches.